Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Emrosi™ (minocycline) – New drug approval

November 4, 2024 - Journey Medical announced the FDA approval of Emrosi (minocycline), to treat inflammatory lesions (papules and pustules) of rosacea in adults.

Download PDF

Rx navigation